{"id":"xelox-intensive-treatment-group","safety":{"commonSideEffects":[{"rate":"20-40%","effect":"Neurotoxicity"},{"rate":"10-30%","effect":"Myelosuppression"},{"rate":"10-20%","effect":"Diarrhea"},{"rate":"10-20%","effect":"Fatigue"},{"rate":"10-20%","effect":"Nausea and vomiting"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"Oxaliplatin is a platinum-based chemotherapy drug that forms platinum-DNA adducts, which interfere with DNA replication and transcription, ultimately leading to cell death. This mechanism is specific to rapidly dividing cells, such as cancer cells.","oneSentence":"Oxaliplatin works by damaging the DNA of cancer cells, preventing them from reproducing.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:14.399Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Colorectal cancer"},{"name":"Advanced colorectal cancer"}]},"trialDetails":[{"nctId":"NCT06609551","phase":"PHASE3","title":"CtDNA-guided Selection of Adjuvant Chemotherapy Regimens for Elderly Colon Cancer Patients After Surgery: a Single-center, Randomized, Controlled Study","status":"RECRUITING","sponsor":"Zhejiang Cancer Hospital","startDate":"2024-07-03","conditions":"Colon Cancer, Colon Cancer (stage II & III)","enrollment":312}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"XELOX intensive treatment group","genericName":"XELOX intensive treatment group","companyName":"Zhejiang Cancer Hospital","companyId":"zhejiang-cancer-hospital","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oxaliplatin works by damaging the DNA of cancer cells, preventing them from reproducing. Used for Colorectal cancer, Advanced colorectal cancer.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}